Rydapt (midostaurin capsules) — Cigna
Myeloid or Lymphoid Neoplasms
Initial criteria
- Patient is age ≥ 18 years
- Patient has eosinophilia
- Patient meets ONE of the following (i or ii): (i) Patient has an FGFR1 rearrangement; OR (ii) Patient has an FLT3 rearrangement
Approval duration
1 year